Investigating the functions of LARGE: Lessons from mutant mice

Methods in Enzymology

Volumn 479, Issue C, 2010, Pages 367-386

  Hewitt, Jane E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; DYSTROPHIN; GLYCOSYLTRANSFERASE; LAMININ; MUCIN; PROTEIN LARGE; UNCLASSIFIED DRUG;

ALLELE; BOOK; CENTRAL NERVOUS SYSTEM; CYTOSKELETON; EXTRACELLULAR MATRIX; EYE DISEASE; GENE MUTATION; GENETIC CODE; GLYCOSYLATION; HETEROZYGOTE; IN SITU HYBRIDIZATION; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR WEIGHT; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SARCOLEMMA; SKELETAL MUSCLE;

ANIMALIA; MUS;

EID: 77956212285     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)79021-2     Document Type: Chapter

References (72)

1. Ackroyd M.R., Skordis L., Kaluarachchi M., Godwin J., Prior S., Fidanboylu M., Piercy R.J., Muntoni F., Brown S.C. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. Brain 2009, 132:439-451.
2. Aguilan J.T., Sundaram S., Nieves E., Stanley P. Mutational and functional analysis of Large in a novel CHO glycosylation mutant. Glycobiology 2009, 19:971-986.
3. Bao X.F., Kobayashi M., Hatakeyama S., Angata K., Gullberg D., Nakayama J., Fukuda M.N., Fukuda M. Tumour supressor function of laminin-binding α-dystroglycan requires a distinct 3-N-acetylglucosaminyltransferase. Proc. Natl. Acad. Sci. USA 2009, 106:12109-12114.
4. Barresi R., Michele D.E., Kanagawa M., Harper H.A., Dovico S.A., Satz J.S., Moore S.A., Zhang W., Schachter H., Dumansk J.P., Cohn R.D., Nishino I., et al. LARGE can functionally bypass α-dystroglycan glycosylation defect in distinct congenital muscular dystrophy. Nat. Med. 2004, 10:696-703.
5. Beltran-Valero de Bernabé D., Inamori K., Yoshida-Moriguchi T., Weydert C.J., Harper H.A., Willer T., Henry M.D., Campbell K.P. Loss of α-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. J. Biol. Chem. 2009, 284:11279-11284.
6. Brockington M., Torelli S., Prandini P., Boito C., Dolatshad N.F., Longman C., Brown S.C., Muntoni F. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy. Hum. Mol. Genet. 2005, 15:657-665.
7. myd mouse, a model of glycosylation-deficient congenital muscular dystrophy. Neuromuscul. Dis. 2005, 15:331-335.
8. Cao W., Henry M.D., Borrow P., Yamada H., Elder J.H., Ravkov E.V., Nichol S.T., Compans R.W., Campbell K.P., Oldstone M.B.A. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis viris and Lassa fever virus. Science 1998, 282:2079-2081.
9. Cohn R.D., Henry M.D., Michele D.E., Barresi R., Saito F., Moore S.A., Flanagan J.D., Skwarchuk M.W., Robbins M.E., Mendell J.R., Williamson R.A., Campbell K.P. Disruption of Dag1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 2002, 110:639-648.
10. Côté P.D., Moukhles H., Lindebaum M., Carbonetto S. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat. Genet. 1999, 23:338-342.
11. Court F.A., Hewitt J.E., Davies K., Patton B.L., Uncini A., Wrabetz L., Feltri M.L. A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments. J. Neurosci. 2009, 29:3908-3919.
12. Dalloz C., Claudepierre T., Rodius F., Mornet D., Sahel J., Rendon A. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: Effect of the mdx(3Cv) mutation. Mol. Cell Neurosci. 2001, 17:908-920.
13. Dumanski J.P., Carlbom E., Collins V.P., Nordenskjold M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc. Natl. Acad. Sci. USA 1987, 84:9275-9279.
14. Durbeej M., Campbell K.P. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opion. Genet. Dev. 2002, 12:349-361.
15. Durbeej M., Henry M.D., Campbell K.P. Dystroglycan in development and disease. Curr. Opion. Cell Biol. 1998, 10:594-601.
16. Emery A.E.H. Resistance to infection and the muscular dystrophies-Is there a molecular link?. Neuromuscul. Dis. 2008, 18:423-425.
17. Frost A.R., Böhm S.V., Sewduth R.N., Josifova D., Ogilvie C.M., Izatt L., Robert R.G. Heterozygous deletion of 2Mb region inlcuding the dystroglycan gene in a patient with mild myopathy, facial hypotonia, oral-motor dyspraxia and white matter abnormalies. Eur. J. Hum. Genet. 2010, 18:852-855.
18. Fujimura K., Sawaki H., Sakai T., Hiruma T., Nakanishi N., Sato T., Ohkura T., Narimatsu H. LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE. Biochem. Biophys. Res. Comm. 2005, 329:1162-1171.
19. Fumagalli M., Pozzoli U., Cagliani R., Comi G.P., Bresolin N., Clerici M., Sironi M. Genome-wide identification of susceptibility alleles for viral infections through a population genetics approach. PLoS Genet. 2010, 6:e1000849.
20. Grewal P.K., Bolland D.J., Carim Todd L., Hewitt J.E. High resolution mapping of mouse chromosome 8 identifies an evolutionary chromosomal breakpoint. Mamm. Genome. 1998, 9:603-607.
21. Grewal P.K., Hewitt J.E. Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy. Biochim. Biophys. Acta 2002, 1573:216-224.
22. Grewal P.K., Holzfeind P.J., Bittner R.E., Hewitt J.E. Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat. Genet. 2001, 28:151-154.
23. Grewal P.K., McLaughlan J.M., Moore C.J., Browning C.A., Hewitt J.E. Characterisation of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. Glycobiology 2005, 15:912-923.
24. Han H., Kanagawa M., Yoshida-Moriguchi T., Rader E.P., Ng R.A., Michele D.E., Muirhead D.E., Kunz S., Moore S.A., Iannaccone S.T., Miyake K., McNeil P.L., et al. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of α-dystroglycan. Proc. Natl. Acad. Sci. USA 2009, 106:12573-12579.
25. Henry M.D., Campbell K.P. Dystroglycan inside and out. Curr. Opin. Cell Biol. 1999, 11:602-607.
26. Herbst R., Iskratsch T., Unger E., Bittner R.E. Aberrant development of neuromuscular junctions in glycosylation-defective Large(myd) mice. Neuromuscul. Dis. 2009, 19:366-378.
27. myd mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders. Hum. Mol. Genet. 2002, 11:2673-2687.
28. Ibraghimov-Beskrovnaya O., Milatovich A., Ozcelik T., Yang B., Koepnick K., Francke U., Campbell K.P. Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue-specific isoforms and chromosomal localization. Hum. Mol. Genet. 1993, 2:1651-1657.
29. Kanagawa M., Nishimoto A., Chiyonobu T., Takeda S., Miyagoe-Suzuki Y., Wang F., Fujikake N., Taniguchi M., Lu Z.P., Tachikawa M., Nagai Y., Tashiro F., et al. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Hum. Mol. Genet. 2009, 18:621-631.
30. Kanagawa M., Saito F., Kunz S., Yoshida-Moriguchi T., Barresi R., Kobayashi Y.M., Muschler J., Dumanski J.P., Michele D.E., Oldstone M.B., Campbell K.P. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 2004, 117:953-964.
31. Kelly D., Chancellor K., Milatovich A., Francke U., Suzuki K., Popko B. Autosomal recessive neuromuscular disorder in a transgenic line. J. Neurosci. 1994, 14:198-207.
32. Kunz S., Rojek J.M., Kanagawa M., Spiropoulou C.F., Barresi R., Campbell K.P., Oldstone M.B. Posttranslational modification of α-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J. Virol. 2005, 79:14282-14296.
33. Lane P.W., Beamer T.C., Myers D.D. Myodystrophy, a new myopathy on chromosome 8 of the mouse. J. Hered. 1976, 67:135-138.
34. Lee Y., Kameya S., Cox G.A., Hsu J., Hicks W., Maddatu T.R., Smith R.S., Naggert J.K., Peachey N.S., Nishina P.M. Ocular abnormalities in Large(myd) and Large(vls) mice, spontaneous models for muscle, eye, and brain diseases. Mol. Cell Neurosci. 2005, 30:160-172.
35. Levedakou E.N., Chen X.-J., Soliven B., Popko B. Disruption of the mouse Large gene in the enr and myd mutants results in nerve, muscle and neuromuscular defects. Mol. Cell Neurosci. 2005, 28:757-769.
36. Levedakou E.N., Popko B. Rewiring enervated: Thinking LARGEr than myodystrophy. J. Neurosci. Res. 2006, 84:237-243.
37. Litwack E.D., Lee Y., Mallott J.M. Absence of the basilar pons in mice lacking a functional Large glycosyltransferase gene suggests a defect in pontine meuron migration. Brain Res. 2006, 1117:12-17.
38. Longman C., Brockington M., Torelli S., Jimenez-Mallebrera C., Kennedy C., Khalil N., Feng L., Saran R.K., Voit T., Merlini L., Sewry C.A., Brown S.C., et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum. Mol. Genet. 2003, 12:2853-2861.
39. Lui J., Ball S.L., Yang Y., Mei P.C., Zhang L., Shi H., Kaminski H.J., Lemmon V.P., Hu H. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1). Mech. Dev. 2006, 123:228-240.
40. Mathews K.D., Rapisarda D., Bailey H.L., Murray J.C., Schleper R.L., Smith R. Phenotypic and pathological evaluation of the myd mouse, a candidate model for facioscapulohumeral dystrophy. J. Neuropath. Exp. Neurol. 1995, 54:601-606.
41. Meier H., MacPike A.D. Myopathies caused by three mutations of the mouse. J. Hered. 1977, 68:383-385.
42. Mercuri E., Messina S., Bruno C., Mora M., Pegoraro E., Comi G.P., D'Amico A., Aiello C., Biancheri R., Berardinelli A., Boffi P., Cassandrini D., et al. Congenital muscular dystrophies with defective glycosylation of dystroglycan. A population study. Neurology 2009, 72:1802-1809.
43. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., Dollar J., Nishino I., Kelley R.I., Somer H., Straub V., Mathews K.D., et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 2002, 418:417-422.
44. Mills K.A., Mathews K.D., Scherpbier-Heddema T., Schleper R.L., Schmalzel R., Bailey H.L., Nadeau J.H., Beutow K.H., Murray J.C. Genetic mapping near the myd locus on mouse chromosome 8. Mamm. Genome 1995, 6:278-280.
45. Miyagoe-Suzuki Y., Masubuchi N., Miyamoto K., Wada M.R., Yuasa S., Saito F., Matsumura K., Kanesaki H., Kudo A., Manya H., Endo T., Takeda S. Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro. Mech. Dev. 2009, 126:107-116.
46. Montanaro F., Carbonetto S., Campbell K.P., Lindenbaum M. Dystroglycan expression in the wild type amd mdx mouse neural retina: synaptic colocalisation with dystrophin, dystrophin-related protein but not with laminin. J. Neurosci. Res. 1995, 42:528-538.
47. Moore S.A., Saito F., Chen J., Michele D.E., Henry M.D., Messing A., Cohn R.D., Ross-Barta S.E., Westra S., Williamson R.A., Hoshi T., Campbell K.P. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 2002, 418:422-425.
48. Muntoni F., Brockington M., Brown S.C. Glycosylation eases muscular dystrophy. Nat. Med. 2004, 10:676-677.
49. Muntoni F., Brockington M., Torelli S., Brown S.C. Defective glycosylation in congenital muscular dystrophies. Curr. Opin. Neurol. 2004, 17:205-209.
50. Patnaik S.K., Stanley P. Mouse Large can modify complex N- and mucin O-glycans on α-dystroglycan to induce laminin binding. J. Biol. Chem. 2005, 280:20851-20859.
51. Peyrard M., Seroussi E., Sandberg-Nordqvist A.-C., Xie Y.-G., Han F.-Y., Fransson I., Collins J., Dunham I., Kost-Alimova M., Imreh S. The human LARGE gene from 22q12.3-q13.1 is a new distinct member of the glycosyltransferase gene family. Proc. Natl. Acad. Sci. USA 1999, 96:598-603.
52. myd mouse are associated with disruption in Bergmann glia organization and delayed migration of granule neurons. Cerebellum 2005, 4:261-270.
53. myd mouse are sssociated with stalled migration in the ventrolateral hindbrain. Eur. J. Neurosci. 2006, 23:2877-2886.
54. Rath E.M., Kelly D., Bouldin T.W., Popko B. Impaired peripheral nerve regeneration in a mutant strain of mice (enr) with a Schwann cell defect. J. Neurosci. 1995, 15:7226-7237.
55. Rayburn H.B., Peterson A.C. Naked axons in myodystrophic mice. Brain Res. 1978, 146:380-384.
56. Rex M., Scotting S.J. In situ hybridisation to sections (non-radioactive). Molecular embryology: Methods and Protocols 1999, 645-654., Humana Press. P.T. Sharpe, I. Mason (Eds.).
57. Rurak J., Noel G., Lui L., Joshi B., Moukhles H. Distribution of potassium ion and water permeable channels at perivascular glia in brain and retina of the Large(myd) mouse. J. Neurochem. 2007, 103:1940-1953.
58. Sabeti P.C., Varilly P., Fry B., Lohmueller J., Hostetter E., Cotsapas C., Xie X.H., Byrne E.H., McCarroll S.A., Gaudet R., Schaffner S.F., Lander E.S. Genome-wide detection and characterization of positive selection in human populations. Nature 2007, 913-919.
59. Saito F., Moore S.A., Barresi R., Henry M.D., Messing A., Ross-Barta S.E., Cohn R.D., Williamson R.A., Sluka K.A., Sherman D.L., Brophy P.J., Schmelzer J.D., et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure and sodium channel stabilization. Neuron 2003, 38:747-758.
60. Santavuori P., Somer H., Sainio K., Rapola J., Kruus S., Nikitin T., Ketonen L., Leisti J. Muscle-eye-brain disease (MEB). Brain Dev. 1989, 11:147-153.
61. Sato S., Omori Y., Katoh K., Kondo M., Kanagawa M., Miyata K.K.F., Koyasu T., Kajimura N., Miyoshi T., Sawai H., Kobayashi K., Tani A., et al. Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat. Neurosci 2008, 11:923-931.
62. Satz J.S., Barresi R., Durbeej M., Willer T., Turner A., Moore S.A., Campbell K.P. Brain and eye malformations resembling Walker-Warburg Syndrome are recapitulated in mice by dystroglycan deletion in the epiblast. J. Neurosci. 2008, 28:10567-10575.
63. Satz J.S., Philp A.R., Nguyen H., Kusano H., Lee J., Turk R., Riker M.J., Hernández J., Weiss R.M., Anderson M.G., Mullins R.F., Moore S.A., et al. Visual impairment in the absence of dystroglycan. J. Neurosci. 2009, 29:13136-13146.
64. Sgambato A., Brancaccio A. The dystroglycan complex: From biology to cancer. J. Cell Physiol. 2005, 205:163-169.
65. Takeda S., Kondo M., Sasaki J., Kurahasi H., Kano H., Arai K., Misaki K., Fukui T., Kobayashi K., Tachikawa M., Imamura M., Nakamura Y., et al. Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development. Hum. Mol. Genet. 2003, 12:1449-1459.
66. Taniguchi M., Kurahashi H., Noguchi S., Fukudome T., Okinaga T., Tsukahara T., Tajima Y., Ozono K., Nishino I., Nonaka I., Toda T. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in α-dystroglycanopathies. Hum. Mol. Genet. 2006, 15:1279-1289.
67. van der Zwaag B., Franke L., Poot M., Hochstenbach R., Spierenburg H.A., Vorstman J.A.S., Daalen E., de Jonge M.V., Verbeek N.E., Brilstra E.H., van 't Slot R., Ophoff R.A., et al. Gene-network analysis identifies susceptibility genes related to glycobiology in autism. PLoS ONE 2009, 4:e5324.
68. van Reeuwijk J., Grewal P.K., Salih M.A.M., de Bernabe D.B.V., McLaughlan J.M., Michielse C.B., Herrmann R., Hewitt J.E., Steinbrecher A., Seidahmed M.Z., Shaheed M.M., Abomelha A., et al. Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome. Hum. Genet. 2007, 121:685-690.
69. Willer T., Prados B., Falcón-Pérez J.M., Renner-Müller I., Przemeck G.K.H., Lommel M., Coloma A., Valero M.C., Hrabé de Angelis M., Tanner W., Wolf E., Strahl S., et al. Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. Proc. Natl. Acad. Sci. USA 2004, 101:14126-14131.
70. Williamson R.A., Henry M.D., Daniels K.J., Hrstka R.F., Lee C.J., Sunada Y., Ibraghimov-Beskrovnaya O., Campbell K.P. Dystroglycan is essential for early embryonic development: disruption of Reichart's membrane in Dag1-null mice. Hum. Mol. Genet. 1997, 6:831-841.
71. Yoshida-Moriguchi T., Liping Y., Stainaker S.H., Davis S., Kunz S., Madson M., Oldstone M.B.A., Schachter H., Wells L., Campbell K.P. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 2010, 327:88-92.
72. Zaccaria M.L., Di Tommaso F., Brancaccio A., Paggi P., Petrucci T.C. Dystroglycan distribution in adult mouse brain: A light and electron microscopy study. Neuroscience 2001, 104:311-324.